Skip to main content

Nicotinic Cholinergic Receptors Labeled with [3H]Acetylcholine in Brain: Characterization, Localization and In Vivo Regulation

  • Chapter
Dynamics of Cholinergic Function

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 30))

  • 17 Accesses

Abstract

There is evidence from behavioral (21), electrophysiological (15) and pharmacological (23) studies that mammalian brain contains a type of nicotinic cholinergic receptor.(nAChR). The utility of alpha-bungarotoxin (α-BTX) for labeling and measuring nAChR in electroplax, skeletal muscle, and certain peripheral neuronal tissues has encouraged similar investigations in the mammalian central nervous system. Although α-BTX binding sites in brain have been extensively characterized in vitro (for review, see 20), the relationship between these binding sites and nAChR is unclear since nicotinic cholinergic drugs are relatively weak competitors for the α-BTX binding sites (16, 24, 30) and the toxin does not appear to block cholinergic function in various neuronal tissues (6, 18).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abood, L.G., Reynolds, D.T. and Bidlack, J.M. (1980): Life Sci. 27: 1307–1314.

    Article  Google Scholar 

  2. Balfour, D.J.K. (1982): Pharmacol. Ther. 16: 269–282.

    Article  Google Scholar 

  3. Clarke, P.B.S., Schwartz, R.D., Paul, S.M., Pert, C.B. and 1 A. (1985): J. Neurosci. 5: 1307–1315.

    Google Scholar 

  4. Costa, L.G. and Murphy, S.D. (1983): J. Pharmacol. Exp. Ther. 226: 392–397.

    Google Scholar 

  5. Creese, I. and Sibley, D. R. (1981): Ann. Rev. Pharmacol. Toxicol. 21: 357–391.

    Google Scholar 

  6. Duggan, A.W., Hall, J.G. and Lee, C.Y. (1976): Brain Res. 107: 166–170.

    Article  Google Scholar 

  7. Ehlert, F.J., Kokka, N. and Fairhurst, A.S. (1980): Mol.Pharmacol. 17: 24–30.

    Google Scholar 

  8. Hillhouse, E.W., Burden, J. and Jones, M.T. (1975): Neuroendocrin. 17: 1–11.

    Article  Google Scholar 

  9. Karlin, A. (1973): Fed. Proc. 32: 1847–1853.

    Google Scholar 

  10. Langer, S.Z. (1977): Br. J. Pharmacol. 60: 481–497.

    Google Scholar 

  11. Marks, M.J., Burch, J.B. and Collins, A.C. (1983): J. Pharmacol. Exp. Ther. 226: 291–302.

    Google Scholar 

  12. Marks, M.J. and Collins, A.C. (1982): Mol. Pharmacol. 23: 554–564.

    Google Scholar 

  13. McGeer, P.L., McGeer, E.G. and Innanen, V.T. (1979): Adv. Neurol. 24: 225–233.

    Google Scholar 

  14. McKinney, M. and Coyle, J.T. (1982): J. Neurosci. 2: 97–105.

    Google Scholar 

  15. McLennan, H. and Hicks,T.P. (1978): Neuropharmacol. 17: 329–334.

    Article  Google Scholar 

  16. McQuarrie, C., Salvaterra, P.M., DeBlas, A., Routes, J. and Mahler, H.R. (1976): J. Biol. Chem. 251: 6335–6339.

    Google Scholar 

  17. Meites, J. (1981): In Brain Neurotransmitters and Receptorsin Aging and Age-Related Disorders, Aging, Vol. 17 (ed)S.J. Enna, Raven Press, New York, pp. 107–115.

    Google Scholar 

  18. Misgeld, U., Weiler, M.H. and Bak, I.J. (1980): Brain Res. 39: 401–409.

    Google Scholar 

  19. Morley, B.J., Lorden, J.F., Brown, G.B., Kemp, G.E. and Bradley, R.J. (1977): Brain Res. 134: 161–166.

    Article  Google Scholar 

  20. Oswald, R.E. and Freeman, J.A. (1981): Neurosci. 6: 1–14.

    Article  Google Scholar 

  21. Pratt, J.A., Stolerman, I.P., Garcha, H.S., Giardini, V. and Feyerabend, C. (1983): Psychopharmacol. 81: 54–60.

    Article  Google Scholar 

  22. Romano, C. and Goldstein, A. (1980): Science 210: 647–649.

    Article  Google Scholar 

  23. Sakurai, Y., Takano, Y., Kohjimoto, Y., Honda, K. and Kamiya, H. (1982): Brain Res. 242: 99–106.

    Article  Google Scholar 

  24. Schmidt, J. (1977): Mol. Pharmacol. 13: 283–290.

    Google Scholar 

  25. Schwartz, R.D. and Kellar, K.J. (1983): Science 220: 213–216.

    Article  Google Scholar 

  26. Schwartz, R.D. and Kellar, K.J. (1983): Mol. Pharmacol. 24: 387–391.

    Google Scholar 

  27. Schwartz, R.D. and Kellar, K.J. (1985): J. Neurochem. In press.

    Google Scholar 

  28. Schwartz, R.D., Lehmann, J. and Kellar, K.J. (1984): J. Neurochem. 42: 1495–1498.

    Article  Google Scholar 

  29. Schwartz, R.D., McGee, R., Jr., and Kellar, K.J. (1982): Mol. Pharmacol. 22: 56–62.

    Google Scholar 

  30. Segal, M., Dudai, Y. and Amsterdam, A. (1978): Brain Res. 148: 105–119.

    Article  Google Scholar 

  31. Sladek, C.D. and Joynt, R.J. (1979): Endocrinol. 104: 659–663.

    Article  Google Scholar 

  32. Thesleff, S. (1955): Physiol. Scandinay. 34: 218–231.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Press, New York

About this chapter

Cite this chapter

Schwartz, R.D., Kellar, K.J. (1986). Nicotinic Cholinergic Receptors Labeled with [3H]Acetylcholine in Brain: Characterization, Localization and In Vivo Regulation. In: Hanin, I. (eds) Dynamics of Cholinergic Function. Advances in Behavioral Biology, vol 30. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5194-8_45

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5194-8_45

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5196-2

  • Online ISBN: 978-1-4684-5194-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics